Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

WuXi PharmaTech (Cayman) Inc (NYSE:WX)

41.50
Delayed Data
As of Jul 31
 0.00 / 0.00%
Today’s Change
30.63
Today|||52-Week Range
46.14
+23.26%
Year-to-Date
No recent news for WuXi PharmaTech (Cayman) Inc.

Today’s Trading

Previous close41.50
Today’s open41.72
Day’s range41.03 - 41.89
Volume410,867
Average volume (3 months)633,501
Market cap$2.9B
Dividend yield--
Data as of 4:02pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-0.51%
Earnings growth (this year)-6.50%
Earnings growth (next 5 years)+11.40%
Revenue growth (last year)+16.05%
P/E ratio26.5
Price/Sales3.61
Price/Book3.71

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+6.47+7.69%
CBPOChina Biologic Produ...+2.57+2.15%
CXRXConcordia Healthcare...-0.05-0.06%
INSYINSYS Therapeutics I...+0.90+2.04%
Data as of 4:01pm ET, 07/31/2015

Financials

Next reporting dateAugust 14, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$671.6M
Annual profit (last year)$111.7M
Net profit margin16.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Ge Li
Chief Operating Officer &
Executive Vice President
Steve Yang
Corporate headquarters
Shanghai, Shanghai

Forecasts